Casdin Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,250,000
| Closed | -$4.31M | – | 55 |
|
|
2020
Q4 | $4.31M | Hold |
6,250,000
| – | – | 0.13% | 48 |
|
|
2020
Q3 | $14.1M | Buy |
6,250,000
+3,300,000
| +112% | +$7.43M | 0.63% | 33 |
|
|
2020
Q2 | $10.6M | Buy |
2,950,000
+450,000
| +18% | +$1.61M | 0.63% | 34 |
|
|
2020
Q1 | $9.5M | Buy |
2,500,000
+1,000,000
| +67% | +$3.8M | 1.01% | 30 |
|
|
2019
Q4 | $4.52M | Buy |
+1,500,000
| New | +$4.52M | 0.42% | 30 |
|